Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development.

Ng A, Wong M, Viviano B, Erlich JM, Alba G, Pflederer C, Jay PY, Saunders S.

Dev Biol. 2009 Nov 1;335(1):208-15. doi: 10.1016/j.ydbio.2009.08.029. Epub 2009 Sep 4.

2.

Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding.

Capurro MI, Xu P, Shi W, Li F, Jia A, Filmus J.

Dev Cell. 2008 May;14(5):700-11. doi: 10.1016/j.devcel.2008.03.006.

3.

Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehog.

Capurro MI, Li F, Filmus J.

EMBO Rep. 2009 Aug;10(8):901-7. doi: 10.1038/embor.2009.98. Epub 2009 Jul 10.

4.

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.

Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J.

J Cell Biol. 1999 Jul 12;146(1):255-64.

5.

The role of glypican-3 in the regulation of body size and cancer.

Filmus J, Capurro M.

Cell Cycle. 2008 Sep 15;7(18):2787-90. Epub 2008 Sep 23.

PMID:
18787398
6.

glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.

Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S.

Dev Biol. 2000 Sep 1;225(1):179-87.

7.

Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice.

Marguerie A, Bajolle F, Zaffran S, Brown NA, Dickson C, Buckingham ME, Kelly RG.

Cardiovasc Res. 2006 Jul 1;71(1):50-60. Epub 2006 Apr 4.

PMID:
16687131
8.

The role of glypicans in Hedgehog signaling.

Filmus J, Capurro M.

Matrix Biol. 2014 Apr;35:248-52. doi: 10.1016/j.matbio.2013.12.007. Epub 2014 Jan 8. Review.

9.

Molecular analysis of a novel intragenic deletion in GPC3 in three cousins with Simpson-Golabi-Behmel syndrome.

Schmidt J, Hollstein R, Kaiser FJ, Gillessen-Kaesbach G.

Am J Med Genet A. 2017 May;173(5):1400-1405. doi: 10.1002/ajmg.a.38188. Epub 2017 Mar 29.

PMID:
28371070
10.
11.

Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.

Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legius E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N, David G.

Hum Mol Genet. 2000 May 22;9(9):1321-8.

PMID:
10814714
12.

Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations.

Yano S, Baskin B, Bagheri A, Watanabe Y, Moseley K, Nishimura A, Matsumoto N, Ray PN.

Clin Genet. 2011 Nov;80(5):466-71. doi: 10.1111/j.1399-0004.2010.01554.x. Epub 2010 Oct 18.

PMID:
20950395
13.

Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as Sonic Hedgehog co-receptors to promote proliferation.

Witt RM, Hecht ML, Pazyra-Murphy MF, Cohen SM, Noti C, van Kuppevelt TH, Fuller M, Chan JA, Hopwood JJ, Seeberger PH, Segal RA.

J Biol Chem. 2013 Sep 6;288(36):26275-88. doi: 10.1074/jbc.M112.438937. Epub 2013 Jul 18.

14.

Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling.

Li F, Shi W, Capurro M, Filmus J.

J Cell Biol. 2011 Feb 21;192(4):691-704. doi: 10.1083/jcb.201008087.

15.

LRP1 mediates Hedgehog-induced endocytosis of the GPC3-Hedgehog complex.

Capurro MI, Shi W, Filmus J.

J Cell Sci. 2012 Jul 15;125(Pt 14):3380-9. doi: 10.1242/jcs.098889. Epub 2012 Mar 30.

16.

The loss of glypican-3 induces alterations in Wnt signaling.

Song HH, Shi W, Xiang YY, Filmus J.

J Biol Chem. 2005 Jan 21;280(3):2116-25. Epub 2004 Nov 10.

17.

Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.

Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A.

Dev Biol. 2002 Mar 1;243(1):185-206.

18.

Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature.

Cottereau E, Mortemousque I, Moizard MP, Bürglen L, Lacombe D, Gilbert-Dussardier B, Sigaudy S, Boute O, David A, Faivre L, Amiel J, Robertson R, Viana Ramos F, Bieth E, Odent S, Demeer B, Mathieu M, Gaillard D, Van Maldergem L, Baujat G, Maystadt I, Héron D, Verloes A, Philip N, Cormier-Daire V, Frouté MF, Pinson L, Blanchet P, Sarda P, Willems M, Jacquinet A, Ratbi I, Van Den Ende J, Lackmy-Port Lis M, Goldenberg A, Bonneau D, Rossignol S, Toutain A.

Am J Med Genet C Semin Med Genet. 2013 May;163C(2):92-105. doi: 10.1002/ajmg.c.31360. Epub 2013 Apr 18. Review.

PMID:
23606591
19.

Novel nonsense mutation of GPC3 gene in a patient with Simpson-Golabi-Behmel syndrome.

Ratbi I, Elalaoui SC, Moizard MP, Raynaud M, Sefiani A.

Turk J Pediatr. 2010 Sep-Oct;52(5):525-8.

PMID:
21434539
20.

GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.

Li M, Shuman C, Fei YL, Cutiongco E, Bender HA, Stevens C, Wilkins-Haug L, Day-Salvatore D, Yong SL, Geraghty MT, Squire J, Weksberg R.

Am J Med Genet. 2001 Aug 1;102(2):161-8.

PMID:
11477610

Supplemental Content

Support Center